• Welcome to Crohn's Forum, a support group for people with all forms of IBD. While this community is not a substitute for doctor's advice and we cannot treat or diagnose, we find being able to communicate with others who have IBD is invaluable as we navigate our struggles and celebrate our successes. We invite you to join us.

Giaconda Limited (GIA)

Igor_Passau

Igor_Passau

Giaconda Limited (Giaconda) is a research focused biotechnology company, engaged in research, development and commercialization of innovative therapeutics for gastrointestinal diseases and disorders. The company focuses broadly on research and development activities in the area of digestive diseases. The pipeline products of the company includes Myoconda, Hepaconda, Heliconda and Ibaconda, and one bowel evacuant Picoconda. Myoconda is a combination antibiotic therapy being developed in Phase III clinical trial for the treatment of crohn's disease. Hepaconda is a combination of bezafibrate and chenodeoxycholic acid. It is in Phase Phase II clinical study for the treatment of hepatitis c virus. Its Heliconda and Picoconda are undergoing Phase III Clinical Trials for the treatment of Resistant Helicobacter pylori infection and Bowel Preparation for

http://reports.pr-inside.com/giaconda-limited-gia-financial-and-r3189911.htm
 
You must log in or register to reply here.
Top